Overall, the nomogram, integrated with deep learning features and clinical data, proved to be a reliable and effective tool for predicting HER2 status, with good predictive accuracy and strong calibration, making it a valuable asset for personalized treatment planning in breast cancer management. This evidence concerns the gene ERBB2 and breast cancer.